Annual Net Income
-$78.95 M
+$48.44 M+38.02%
31 December 2023
Summary:
Protagonist Therapeutics annual net profit is currently -$78.95 million, with the most recent change of +$48.44 million (+38.02%) on 31 December 2023. During the last 3 years, it has fallen by -$12.80 million (-19.36%). PTGX annual net income is now -613.11% below its all-time high of -$11.07 million, reached on 31 December 2014.PTGX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$33.21 M
-$2.59 M-8.47%
30 September 2024
Summary:
Protagonist Therapeutics quarterly net profit is currently -$33.21 million, with the most recent change of -$2.59 million (-8.47%) on 30 September 2024. Over the past year, it has increased by +$895.00 thousand (+2.62%). PTGX quarterly net income is now -116.02% below its all-time high of $207.34 million, reached on 31 March 2024.PTGX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$170.85 M
+$895.00 K+0.53%
30 September 2024
Summary:
Protagonist Therapeutics TTM net profit is currently $170.85 million, with the most recent change of +$895.00 thousand (+0.53%) on 30 September 2024. Over the past year, it has increased by +$311.33 million (+221.61%). PTGX TTM net income is now at all-time high.PTGX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.0% | +2.6% | +221.6% |
| 3 y3 years | -19.4% | +1.8% | +258.9% |
| 5 y5 years | -102.8% | -102.4% | +332.3% |
PTGX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -19.4% | +38.0% | -116.0% | +19.1% | at high | +221.6% |
| 5 y | 5 years | -102.8% | +38.0% | -116.0% | +19.1% | at high | +221.6% |
| alltime | all time | -613.1% | +38.0% | -116.0% | +19.1% | at high | +221.6% |
Protagonist Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$33.21 M(+8.5%) | $170.85 M(+0.5%) |
| June 2024 | - | -$30.62 M(-114.8%) | $169.95 M(+4.8%) |
| Mar 2024 | - | $207.34 M(+658.5%) | $162.11 M(-305.3%) |
| Dec 2023 | -$78.95 M(-38.0%) | $27.34 M(-180.1%) | -$78.95 M(-43.8%) |
| Sept 2023 | - | -$34.10 M(-11.3%) | -$140.48 M(+2.1%) |
| June 2023 | - | -$38.46 M(+14.0%) | -$137.61 M(-1.8%) |
| Mar 2023 | - | -$33.73 M(-1.4%) | -$140.19 M(+10.0%) |
| Dec 2022 | -$127.39 M(+1.5%) | -$34.19 M(+9.5%) | -$127.39 M(-2.1%) |
| Sept 2022 | - | -$31.23 M(-23.9%) | -$130.11 M(-1.9%) |
| June 2022 | - | -$41.04 M(+96.1%) | -$132.68 M(+8.3%) |
| Mar 2022 | - | -$20.93 M(-43.3%) | -$122.48 M(-2.4%) |
| Dec 2021 | -$125.55 M(+89.8%) | -$36.91 M(+9.2%) | -$125.55 M(+16.8%) |
| Sept 2021 | - | -$33.80 M(+9.6%) | -$107.53 M(+32.0%) |
| June 2021 | - | -$30.84 M(+28.5%) | -$81.49 M(+16.3%) |
| Mar 2021 | - | -$24.00 M(+27.1%) | -$70.07 M(+5.9%) |
| Dec 2020 | -$66.15 M(-14.3%) | -$18.89 M(+143.3%) | -$66.15 M(+2.1%) |
| Sept 2020 | - | -$7.76 M(-60.0%) | -$64.77 M(-11.8%) |
| June 2020 | - | -$19.42 M(-3.3%) | -$73.41 M(-11.7%) |
| Mar 2020 | - | -$20.08 M(+14.7%) | -$83.16 M(+7.7%) |
| Dec 2019 | -$77.19 M | -$17.50 M(+6.7%) | -$77.19 M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$16.41 M(-43.8%) | -$73.55 M(+11.6%) |
| June 2019 | - | -$29.17 M(+106.9%) | -$65.88 M(+45.2%) |
| Mar 2019 | - | -$14.10 M(+1.7%) | -$45.37 M(+16.6%) |
| Dec 2018 | -$38.92 M(+5.3%) | -$13.87 M(+58.7%) | -$38.92 M(+38.5%) |
| Sept 2018 | - | -$8.73 M(+0.8%) | -$28.11 M(+16.2%) |
| June 2018 | - | -$8.66 M(+13.1%) | -$24.20 M(-20.7%) |
| Mar 2018 | - | -$7.66 M(+151.0%) | -$30.52 M(-17.4%) |
| Dec 2017 | -$36.96 M(-0.6%) | -$3.05 M(-36.7%) | -$36.96 M(-18.2%) |
| Sept 2017 | - | -$4.83 M(-67.8%) | -$45.15 M(-4.8%) |
| June 2017 | - | -$14.98 M(+6.2%) | -$47.41 M(+19.9%) |
| Mar 2017 | - | -$14.10 M(+25.4%) | -$39.53 M(+6.3%) |
| Dec 2016 | -$37.18 M(+150.2%) | -$11.25 M(+58.8%) | -$37.18 M(+18.3%) |
| Sept 2016 | - | -$7.08 M(-0.2%) | -$31.42 M(+13.1%) |
| June 2016 | - | -$7.10 M(-39.6%) | -$27.79 M(+16.2%) |
| Mar 2016 | - | -$11.75 M(+113.9%) | -$23.91 M(+60.9%) |
| Dec 2015 | -$14.86 M(+34.2%) | -$5.49 M(+59.3%) | -$14.86 M(+58.7%) |
| Sept 2015 | - | -$3.45 M(+7.1%) | -$9.37 M(+58.3%) |
| June 2015 | - | -$3.22 M(+19.4%) | -$5.92 M(+119.4%) |
| Mar 2015 | - | -$2.70 M | -$2.70 M |
| Dec 2014 | -$11.07 M | - | - |
FAQ
- What is Protagonist Therapeutics annual net profit?
- What is the all time high annual net income for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual net income year-on-year change?
- What is Protagonist Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly net income year-on-year change?
- What is Protagonist Therapeutics TTM net profit?
- What is the all time high TTM net income for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM net income year-on-year change?
What is Protagonist Therapeutics annual net profit?
The current annual net income of PTGX is -$78.95 M
What is the all time high annual net income for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual net profit is -$11.07 M
What is Protagonist Therapeutics annual net income year-on-year change?
Over the past year, PTGX annual net profit has changed by +$48.44 M (+38.02%)
What is Protagonist Therapeutics quarterly net profit?
The current quarterly net income of PTGX is -$33.21 M
What is the all time high quarterly net income for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly net profit is $207.34 M
What is Protagonist Therapeutics quarterly net income year-on-year change?
Over the past year, PTGX quarterly net profit has changed by +$895.00 K (+2.62%)
What is Protagonist Therapeutics TTM net profit?
The current TTM net income of PTGX is $170.85 M
What is the all time high TTM net income for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM net profit is $170.85 M
What is Protagonist Therapeutics TTM net income year-on-year change?
Over the past year, PTGX TTM net profit has changed by +$311.33 M (+221.61%)